Loading company…
Metware develops metabolomics technology and related research and diagnostic products.
Founded in 2015 and based in Wuhan, China, Metware provides metabolomics research services and develops kits for chronic metabolic disease prognosis and early tumor screening. Its products serve fields including cancer, infectious disease, agriculture, and microbiome research. In April 2024, it closed a Series B round led by Hidea Investment.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in